UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Impact of EBV Status on Characteristics and Outcomes of Posttransplantation Lymphoproliferative Disorder

American journal of transplantation, 2015-10, Vol.15 (10), p.2665-2673

2015

Volltextzugriff (PDF)

Phase I Study of Recombinant Human CD40 Ligand in Cancer Patients

Journal of clinical oncology, 2001-07, Vol.19 (13), p.3280-3287

2001

Volltextzugriff (PDF)

The Telomerase Catalytic Subunit Is a Widely Expressed Tumor-Associated Antigen Recognized by Cytotoxic T Lymphocytes

Immunity (Cambridge, Mass.), 1999-06, Vol.10 (6), p.673-679

1999

Volltextzugriff (PDF)

RNA-loaded CD40-activated B cells stimulate antigen-specific T-cell responses in dogs with spontaneous lymphoma

Gene therapy, 2008-07, Vol.15 (13), p.955-965

2008

Volltextzugriff (PDF)

Rare naturally occurring immune responses to three epitopes from the widely expressed tumour antigens hTERT and CYP1B1 in multiple myeloma patients

Clinical and experimental immunology, 2005-09, Vol.141 (3), p.558-562

2005

Volltextzugriff (PDF)

CD25 blockade depletes and selectively reprograms regulatory T cells in concert with immunotherapy in cancer patients

Science translational medicine, 2012-05, Vol.4 (134), p.134ra62

2012

Volltextzugriff (PDF)

Immunoglobulin framework-derived peptides function as cytotoxic T-cell epitopes commonly expressed in B-cell malignancies

Nature medicine, 2000-06, Vol.6 (6), p.667-672

2000

Volltextzugriff (PDF)

Association of thrombocytopenia with the use of intra-aortic balloon pumps

The American journal of medicine, 1998-07, Vol.105 (1), p.27-32

1998

Volltextzugriff (PDF)

Universal tumor antigens as targets for immunotherapy

Cytotherapy (Oxford, England), 2002-07, Vol.4 (4), p.317-327

2002

Volltextzugriff (PDF)

The spleen as a diagnostic specimen: a review of 10 years' experience at two tertiary care institutions

Cancer, 2001-06, Vol.91 (11), p.2001-2009

2001

Volltextzugriff (PDF)

HER-2/neu and hTERT Cryptic Epitopes as Novel Targets for Broad Spectrum Tumor Immunotherapy

The Journal of immunology (1950), 2002-06, Vol.168 (11), p.5900-5906

2002

Volltextzugriff (PDF)

Telomerase as a universal tumor-associated antigen for cancer immunotherapy

Oncogene, 2002-01, Vol.21 (4), p.674-679

Vonderheide, R H

2002

Volltextzugriff (PDF)

Melanoma Inhibitor of Apoptosis Protein (ML-IAP) Is a Target for Immune-Mediated Tumor Destruction

Proceedings of the National Academy of Sciences - PNAS, 2003-03, Vol.100 (6), p.3398-3403

2003

Volltextzugriff (PDF)

Characterization of HLA-A3-restricted Cytotoxic T Lymphocytes Reactive against the Widely Expressed Tumor Antigen Telomerase

Clinical cancer research, 2001-11, Vol.7 (11), p.3343-3348

2001

Volltextzugriff (PDF)

Abstract ES6-3: Opportunities for immune therapy and prevention

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.ES6-3-ES6-3

Vonderheide, RH

2018

Volltextzugriff (PDF)

From cancer genomics to cancer immunotherapy: toward second-generation tumor antigens

Trends in Immunology, 2001-09, Vol.22 (9), p.516-523

2001

Volltextzugriff (PDF)

Residues within a Conserved Amino Acid Motif of Domains 1 and 4 of VCAM-1 Are Required for Binding to VLA-4

The Journal of cell biology, 1994-04, Vol.125 (1), p.215-222

1994

Volltextzugriff (PDF)

Final Results of a Phase I “RadVax” Trial of Hypofractionated Radiation Combined With Pembrolizumab in Patients With Metastatic Solid Tumors

International journal of radiation oncology, biology, physics, 2021-11, Vol.111 (3), p.S67-S68

2021

Volltextzugriff (PDF)

Lymphocyte adhesion through very late antigen 4: evidence for a novel binding site in the alternatively spliced domain of vascular cell adhesion molecule 1 and an additional alpha 4 integrin counter-receptor on stimulated endothelium

The Journal of experimental medicine, 1992-06, Vol.175 (6), p.1433-1442

1992

Volltextzugriff (PDF)

Equivalent induction of telomerase-specific cytotoxic T lymphocytes from tumor-bearing patients and healthy individuals

Cancer research (Chicago, Ill.), 2001-12, Vol.61 (23), p.8366-8370

2001

Volltextzugriff (PDF)

Generation of cytotoxic T lymphocytes against native and altered peptides of human leukocyte antigen-A0201 restricted epitopes from the human epithelial cell adhesion molecule

Cancer research (Chicago, Ill.), 2001-06, Vol.61 (12), p.4761-4765

2001

Volltextzugriff (PDF)

CD40 activation of carcinoma cells increases expression of adhesion and major histocompatibility molecules but fails to induce either CD80/CD86 expression or T cell alloreactivity

International journal of oncology, 2001-10, Vol.19 (4), p.791

2001

Volltextzugriff (PDF)

Telomerase as a universal tumor-associated antigen for cancer immunotherapy

Oncogene, 2002-01, Vol.21 (4), p.674-679

Vonderheide, Robert H

2002

Volltextzugriff (PDF)

Tumour immunotherapy: new tools, new treatment modalities and new T-cell antigens

Vox sanguinis, 2001-02, Vol.80 (2), p.81-89

2001

Volltextzugriff (PDF)

Vaccination of Cancer Patients Against Telomerase Induces Functional Antitumor CD8+ T Lymphocytes

Clinical cancer research, 2004-02, Vol.10 (3), p.828-839

2004

Volltextzugriff (PDF)

1 – 25 von 166

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(154)
Mit Volltextzugriff
(152)

Publikationsform

Sprache

Englisch
(166)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Impact of EBV Status on Characteristics and Outcomes of Posttransplantation Lymphoproliferative Disorder

Phase I Study of Recombinant Human CD40 Ligand in Cancer Patients

The Telomerase Catalytic Subunit Is a Widely Expressed Tumor-Associated Antigen Recognized by Cytotoxic T Lymphocytes

RNA-loaded CD40-activated B cells stimulate antigen-specific T-cell responses in dogs with spontaneous lymphoma

Rare naturally occurring immune responses to three epitopes from the widely expressed tumour antigens hTERT and CYP1B1 in multiple myeloma patients

CD25 blockade depletes and selectively reprograms regulatory T cells in concert with immunotherapy in cancer patients

Immunoglobulin framework-derived peptides function as cytotoxic T-cell epitopes commonly expressed in B-cell malignancies

Association of thrombocytopenia with the use of intra-aortic balloon pumps

Universal tumor antigens as targets for immunotherapy

The spleen as a diagnostic specimen: a review of 10 years' experience at two tertiary care institutions

HER-2/neu and hTERT Cryptic Epitopes as Novel Targets for Broad Spectrum Tumor Immunotherapy

Telomerase as a universal tumor-associated antigen for cancer immunotherapy

Melanoma Inhibitor of Apoptosis Protein (ML-IAP) Is a Target for Immune-Mediated Tumor Destruction

Characterization of HLA-A3-restricted Cytotoxic T Lymphocytes Reactive against the Widely Expressed Tumor Antigen Telomerase

Abstract ES6-3: Opportunities for immune therapy and prevention

From cancer genomics to cancer immunotherapy: toward second-generation tumor antigens

Residues within a Conserved Amino Acid Motif of Domains 1 and 4 of VCAM-1 Are Required for Binding to VLA-4

Final Results of a Phase I “RadVax” Trial of Hypofractionated Radiation Combined With Pembrolizumab in Patients With Metastatic Solid Tumors

Lymphocyte adhesion through very late antigen 4: evidence for a novel binding site in the alternatively spliced domain of vascular cell adhesion molecule 1 and an additional alpha 4 integrin counter-receptor on stimulated endothelium

Equivalent induction of telomerase-specific cytotoxic T lymphocytes from tumor-bearing patients and healthy individuals

Generation of cytotoxic T lymphocytes against native and altered peptides of human leukocyte antigen-A0201 restricted epitopes from the human epithelial cell adhesion molecule

CD40 activation of carcinoma cells increases expression of adhesion and major histocompatibility molecules but fails to induce either CD80/CD86 expression or T cell alloreactivity

Telomerase as a universal tumor-associated antigen for cancer immunotherapy

Tumour immunotherapy: new tools, new treatment modalities and new T-cell antigens

Vaccination of Cancer Patients Against Telomerase Induces Functional Antitumor CD8+ T Lymphocytes

Suchergebnisse filtern